Summary
From funding and investment woes, to the changing regulatory landscape, new legislation, and updated accounting regulations, the medical device sector, like many others in life sciences, faces unique business and product development challenges in 2009. During this recent breakfast program hosted by Goodwin Procter, partner Raymond Zemlin paired with key industry and investor participants for three mini panel discussions: The Medical Device Investment Market, Regulatory Issues and Developments at the FDA, and Accounting, 141(R) and Its Impact on Acquisition Structures.
Speakers
- /en/people/z/zemlin-raymond
Raymond C. Zemlin
PartnerRetired Partner